SMN2 and spinal muscular atrophy, type 1: The number of copies of SMN2 in the patient's genome largely determines the severity of the clinical presentation, spanning from SMA type I, the early onset and most severe form that is generally associated with two SMN2 copies, to the less severe SMN II‐IV forms, in which patients usually harbour multiple SMN2 copies 2.